Beverly Hills-based Nordicus Partners Corp. entered into a stock purchase and sale agreement to acquire Bio-Convert ApS for $60.6 million on November 11.
Irvine-headquartered Edwards Lifesciences has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) for $4.2 billion in an all-cash transaction.
PharmaLogic, a contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, has announced the official opening of its radiopharmaceutical production and research facility in Los Angeles, according to a press release.
City of Hope has received a historic $150-million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to immediately fund pancreatic cancer research.
New Keck Medicine of USC research published in Advances in Wound Care suggests there may be a more effective method to detect bacteria during wound debridement.
City of Hope Orange County, part of one of the largest cancer research and treatment organizations in the United States, has announced that world-renowned colorectal surgeon Alessio Pigazzi, M.D., Ph.D., has joined the organization as clinical professor of surgery, executive medical director of colorectal surgery and vice chair of clinical network affairs for the Department of Surgery.
Irvine-based Edwards Lifesciences Corp. agreed to acquire Endotronix Inc. on July 24.
The Healthcare, Biotech & Life Sciences Roundtable panel is produced by the L.A.
Triton Pacific Healthcare Partners, a Los Angeles-based and healthcare-focused private equity group, has announced the closing of its sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners.
Biocom California, the association representing the California life science industry, has announced that it has named Tim Scott as its president and CEO, effective January 1, 2025.
